News

Novartis Projects 5% Annual Sales Growth In CC Through 2031, Sustained Growth Over Long Term

NASDAQ

(RTTNews) - Swiss drug major Novartis AG (NVS, NOVN.SW) Thursday announced its mid-term guidance to 2026-2031, with net sales expected to grow 5 percent at constant currency CAGR. The firm added that core operating income margin is on track to return to more than 40 percent by 20

Read the full Veytics brief

We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.